Emerging research suggest this peptide, a dual stimulator targeting both GLP-1 and another hormone, may provide a significant step forward for body loss . Preliminary patient trials have demonstrated substantial decreases in visceral fat , conceivably surpassing other obesity therapies . However , more assessment is necessary to completely understa